Journal Home
Contents
Editorial Board
Instructions for Contributors
Subscription Rates
© Neva Press, Inc. 2005 |
|
CNS Drug ReviewsTable
of Contents
Volume 2, No. 4
| 363 |
|
FG 5893: A
Potential New Generation Anxiolytic/Antidepressant Drug With High Affinity for both 5HT1A
and 5HT2A Receptors
Gunnar Andersson, Agneta Albinsson, Anders Björk and Jan Svartengren |
| 390 |
|
Flumazenil
D. Bentué-Ferrer, M. Bureau, A. Patat, H. Allain |
| 415 |
|
Pharmacological
Properties of a Putative 5HT1B-D Receptor Antagonist GR-127,935
Petrus J. Pauwels |
| 429 |
|
Endogenous and
Synthetic Cannabinoids: Recent Advances
Esther Shohami, Joseph Weidenfeld, Haim Ovdia, Zvi Vogel, Lumir Hamis, Ester Fride,
Aviva Breuer, Shimon Ben-Shabat, Tzviel Sheskin, Raphael Mechoulam |
| 452 |
|
Interaction of New
and Potential Antiepileptics With Conventional Antiepileptic Drugs in Clinical Trials and
Experimental Models of Epilepsy
S. J. Czuszwar, Z. Kleinrok and W. A. Turski |
| 468 |
|
SUBJECT
INDEX for Volume 2 |
| 471 |
|
AUTHOR
INDEX for Volume 2 |
|
|
|